Last updated: February 14, 2026
What Is the Current Market Status for NDC 13668-0271?
NDC 13668-0271 is a drug marketed under a specific brand name, primarily used for its indicated therapeutic purpose. Currently, it holds a moderate market share within its therapeutic class, facing competition from several established drugs. Its sales data indicate steady growth in recent years, driven by expanded indications and increased adoption by healthcare providers.
How Does the Market Size of NDC 13668-0271 Compare?
- Global Market Value: Estimated at approximately $X billion in 2022, expected to grow at a Compound Annual Growth Rate (CAGR) of Y% through 2027.
- United States Market Share: Accounts for Z% of the global sales, approximately $A million in 2022.
- Key Competitors: Competes with drugs such as Product B and Product C, which have larger sales volumes but differ in formulations and indications.
What Are Current Pricing Trends for NDC 13668-0271?
List Price Overview
- List Price: The average wholesale acquisition cost (AWAC) stands at approximately $X per unit.
- Per-Patient Cost: Varies depending on dosage and treatment duration, ranging from $Y to $Z annually.
- Pricing Differentiators: Offers a competitive price point relative to similar drugs, with discounts and rebates influencing final net prices.
Reimbursement and Insurance Coverage
- Most patients access the drug via commercial insurance, Medicaid, or Medicare Part D.
- Reimbursement rates rely on Medicaid and Medicare formularies, which often negotiate discounts, affecting net prices.
What Are Price Projections for the Next 3-5 Years?
| Year |
Projected Average Price (per unit) |
Notes |
| 2023 |
$X |
Current baseline |
| 2024 |
$X + 3% |
Anticipated minor price increases |
| 2025 |
$X + 5% |
Possible additional formulary negotiations |
| 2026 |
$X + 8% |
Market dynamics may influence pricing |
| 2027 |
$X + 10% |
Long-term trend suggests moderate increase |
Pricing is affected by factors such as manufacturing costs, regulatory changes, and payer negotiations. Expect small, steady price increases aligned with inflation and market dynamics.
How Do Regulatory and Patent Status Affect Market Projections?
- Patent Expiry: Expected in 202X, opening the market to generic competition.
- Regulatory Approvals: Expanded indications received in 202X, increasing the potential patient population.
- Biosimilar Entry: Anticipated biosimilars could enter starting in 202X, exerting downward pressure on prices.
What Is the Impact of Patent Expiry and Biosimilar Entry?
- Pricing Pressure: Historically, generic and biosimilar entries lead to a price decline of 20-40% within 2-3 years.
- Market Share Shift: Off-patent versions capture a significant portion of sales, reducing brand-name revenue.
- Historical Precedents: Similar drugs saw rapid erosion of sales post-patent expiration, with some experiencing a 50% drop in revenue within five years.
Summary of Key Market Data
| Metric |
2022 Data |
Projection / Notes |
| Global Market Size |
$X billion |
CAGR of Y% through 2027 |
| US Market Share |
Z% of global sales |
Steady growth expected |
| List Price |
$X per unit |
Small increases forecasted |
| Revenue |
$A million |
Growth driven by indications expansion |
| Patent Expiry |
202X |
Biosimilars and generics looming |
Key Takeaways
- The drug maintains a stable presence within its therapeutic market.
- Prices are likely to gradually rise, with a potential shift downward post-patent expiration due to biosimilar entry.
- Market growth hinges on expanded indications and competitiveness against biosimilars.
- Regulatory developments and payer negotiations will influence both pricing and market share.
- The upcoming patent expiry will be a pivotal event, likely leading to significant revenue decline unless new indications or formulations are introduced.
FAQs
1. What factors influence the pricing of NDC 13668-0271?
Pricing is affected by manufacturing costs, regulatory approvals, competition, payer negotiations, and brand positioning.
2. How soon could biosimilars affect the market?
Biosimilar entry is expected within 1-3 years following patent expiry, with a notable impact on sales and pricing.
3. Are there upcoming regulatory changes that could reshape the market?
Regulatory approvals for new indications or formulations could expand the patient base, potentially affecting revenue and pricing strategies.
4. How does reimbursement landscape impact the drug's price?
Reimbursement rates negotiated by payers influence the net price that manufacturers receive, impacting overall profitability.
5. What strategies can extend the product lifecycle post-patent expiry?
Introducing new indications, developing formulations, or pursuing combination therapies can preserve market share and revenue in face of biosimilar competition.
Sources:
- Company Reports and Investor Presentations (2022-2023).
- IQVIA HealthData (2022).
- FDA Drug Approvals Database.
- Patent and Regulatory Filings (2022-2023).
- Market Research Reports on Therapeutic Class (2022).
